跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NORDIMET - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NORDIMET
Authorized
STANDARD
NORDIMET
Nordic Group BV
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
12fbda0337426f8a
Company
Nordic Group BV
Type
Standard
Approval Details
Approval Id
12fbda0337426f8a
Drug Approval Canada Name
NORDIMET
Product Name
NORDIMET
Status
Approved
Status Date
2024-03-26
Din
02546604
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription
Ahfs
90:28.00
Atc Original
L04AX03 METHOTREXATE
Atc Name
l 04 ax 03
Aig Number
0107545002
Company Name
Nordic Group BV
Company Address
Siriusdreef 41, Hoofddorp, Noord-Holland, Netherlands, 2132 WT
Company Detail Path
/organization/nordic-group-bv
Company Information
Pharmaceutical Company Name
Nordic Group BV
Country Name
Netherlands
Website
http://www.nordicpharma.com
Active Ingredients
METHOTREXATE (METHOTREXATE SODIUM)
22.5 MG / 0.9 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
12fbda0337426f8a
Type
Standard
Back to Health Canada Approvals